REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Morison Plc (Sri Lanka)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers | Chemical and Allied Products Merchant Wholesalers
Full name: Morison Plc Profile Updated: June 29, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English Download a sample report

morison Ltd. is a pharmaceutical manufacturing company. The company specializes in developing and manufacturing high-demand medicines such as morison Lacto Cream, Lacto Lotion, and Lacto Calamine Lotion and Powder. morison has also installed the first high-capacity, fully automated COVID PCR unit.

Legal Address
Hemas House No. 75 Braybrooke Place
Colombo; Western Province; Postal Code: 02

Contact Details: Purchase the Morison Plc report to view the information.

Website: http://www.morison.lk

Basic Information
Total Employees:
Purchase the Morison Plc report to view the information.
Outstanding Shares:
Purchase the Morison Plc report to view the information.
Financial Auditors:
Purchase the Morison Plc report to view the information.
Incorporation Date:
1939
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member Of The Board
Purchase this report to view the information.
Director/Member Of The Board
Purchase this report to view the information.
Director/Member Of The Board
Purchase this report to view the information.
Director/Member Of The Board
Ownership Details
Purchase this report to view the information.
88.83%
Subsidiaries
Compak Morison (Lanka) Ltd.
100%
M. S. J. Cargoes (Ceylon) Ltd.
100%
M. S. J. Foods (Ceylon) Ltd.
100%
Company Performance
Financial values in the chart are available after Morison Plc report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency LKR. Absolute financial data is included in the purchased report.
Net sales revenue
14.84%▲
Total operating revenue
14.7%▲
Operating profit (EBIT)
76.18%▲
EBITDA
26.35%▲
Net Profit (Loss) for the Period
N/A
Total assets
32.47%▲
Total equity
4.07%▲
Operating Profit Margin (ROS)
0.82%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
36.3%▲
Quick Ratio
-0.56%▼
Cash Ratio
-0.37%▼

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo